Clincosm LogoSign in Get a demo

The Effect of Bone Mineral Density in Patients With Adult Cystic Fibrosis

Sponsor
Hacettepe University (Other)
Overall Status
Recruiting
CT.gov ID
NCT06088485
Collaborator
(none)
60
Enrollment
1
Location
5.4
Anticipated Duration (Months)
11.1
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The study was conducted in the age range of 18-45 December, who were diagnosed with Cystic fibrosis.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    60 voluntary patients who have signed the consent form will be included. Within the scope of the research the demographic information of the individuals will be recorded. Functional capacities of individuals With the Shuttle Walking Test at Increasing Speed, respiratory functions respiratory function test, with measurements of respiratory November muscle strength and endurance, the level of dyspnea was Modified Medical Peripheral November muscle strength hand dynamometers with Research Council (mMRC) Dyspnea Scale posture assessment with the Corbin Posture Analysis Scale, trunk mobility with the Trunk Pelvis-Hip Angle Test, core stabilization with Sahrmann's Core Stability Test, individuals' perception of cosmetic deformity Walter Reed visual assessment questionnaires

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    60 participants
    Observational Model:
    Case-Control
    Time Perspective:
    Prospective
    Official Title:
    Erişkin Kistik Fibrozisli Bireylerde Kemik Mineral Yoğunluğunun Postür, Solunum Fonksiyonları ve Fonksiyonel Egzersiz Kapasitesi Üzerine Etkisi
    Actual Study Start Date :
    Sep 5, 2023
    Anticipated Primary Completion Date :
    Jan 22, 2024
    Anticipated Study Completion Date :
    Feb 16, 2024

    Arms and Interventions

    Arm Intervention/Treatment
    low bone mineral density

    bone mineral density according to t and z score.
    normal bone mineral density

    bone mineral density according to t and z score.

    Outcome Measures

    Primary Outcome Measures

    1. Functional Exercise Capacity [1 day]

      Functional exercise capacity by incremental shuttle walk test in patients with adult Cystic Fibrosis

    Secondary Outcome Measures

    1. Posture [1 day]

      posture by Corbin Posture Analysis Form in patients with adult Cystic Fibrosis

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 45 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • bla bla bla
    Exclusion Criteria:
    • bla bla bla

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Hacettepe University, Health Sciences Faculty Ankara Turkey 06100

    Sponsors and Collaborators

    • Hacettepe University

    Investigators

    • Principal Investigator: Aynur Demirel, Hacettepe University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Aynur Demirel, PT, PhD, Assoc. Prof., Hacettepe University
    ClinicalTrials.gov Identifier:
    NCT06088485
    Other Study ID Numbers:
    • GO22/126
    First Posted:
    Oct 18, 2023
    Last Update Posted:
    Oct 18, 2023
    Last Verified:
    Oct 1, 2023
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:
    Cystic Fibrosis
    Fibrosis

    Study Results

    No Results Posted as of Oct 18, 2023